Inve India ▾

Health X Platform share price & results

Health X Platform Limited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Healthcare ecosystem operator (formerly Sastasundar Ventures) trading, distributing and e-commerce-selling medicines & diagnostics via subsidiary Sastasundar Healthbuddy, alongside an NBFC financial-services arm (Microsec Resources) now bei

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue0.08 ₹ crore−20.0% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin-625.0 %−335.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-0.51 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity-2.78 %−4.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-6.47 %−4.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)28.85 %+37.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

2 of 4 judged targets kept · 11 open · verdicts reflect calls analysed to Q1 FY27.

Health X Platform Limited management guidance track record on Inve: 15 targets tracked across analysed earnings calls (2 achieved, 2 missed, 11 open).

TargetOriginal wordingSaidLatest callVerdict
Consolidated PAT PositivityAchieve consolidated PAT positivity in FY26/FY27 (supported by treasury income)
Call transcript, Q2 FY26 · 17 Nov 2025		Q2 FY26Q1 FY27:Returned to positive quarterly PAT of ₹2 crores in Q1 FY27.
Call transcript, Q1 FY27 · 11 Aug 2026		Achieved*
Consolidated Company EBITDA Margin (Q4 FY26)1% consolidated EBITDA margin in Q4 FY26
Call transcript, Q4 FY25 · 12 Jun 2025		Q4 FY25Q1 FY27:Reported Q1 FY27 EBITDA loss of ₹15 cr (-3.4% margin) and explicitly stated the company will not be EBITDA positive for the next 2-3 years.
Call transcript, Q1 FY27 · 11 Aug 2026		Missed
RetailerShakti EBITDA Positivity and 1% Full-Year MarginPositive EBITDA by Q4 FY26 and 1% full-year EBITDA margin for RetailerShakti in FY26
Call transcript, Q4 FY25 · 12 Jun 2025		Q4 FY25Q1 FY27:Slipped back to 'closer to break even' in Q1 FY27 amid multi-state expansion; pushed positive quarterly EBITDA expectation to Q3 FY27.
Call transcript, Q1 FY27 · 11 Aug 2026		Delayed

Source: Inve Guidance Tracker for Health X Platform Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of Health X Platform Limited's 15 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 12 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹275.4 +2.19% · +₹5.9

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −8.8% 1Y

₹260₹280₹300₹320₹340Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 17 Nov 2025Q3 FY26 — 16 Feb 2026Q4 FY26 — 19 Jun 2026Q1 FY27 — 11 Aug 2026

1Y: ₹302.05 on 24 Oct 2025 → ₹275.4. High ₹337.6 (13 Jul 2026), low ₹256.95 (30 Mar 2026).

Previous close
₹269.5
Market cap
₹857 Cr
52-week range
₹256.95 – ₹337.6
One year
−9.32%
Price to earnings (FY ending Mar 2026)
214.25×
Return on equity (TTM to Jun 2026)
-2.78%

Overview

Symbol
NSE:HEALTHX
Exchange
NSE
Currency
INR

What Health X Platform Limited does

Based on the company's own presentations, annual report and earnings calls.

Health X Platform Limited runs a group of subsidiaries spanning two business segments: healthcare services (pharmaceutical trading and distribution, plus e-commerce sale of medicines and diagnostics through Sastasundar Healthbuddy Limited) and financial services (lending, investments, wealth management and advisory through Microsec Resources Private Limited, a registered NBFC). It also operates Innogrow Technologies, which provides end-to-end IT, digital technology and IT-enabled services to the group. The company sells to consumers directly and to retailers through its B2B platform Retailer Shakti, and is executing a scheme to demerge the financial-services business into Microsec Resources while merging Sastasundar Healthbuddy into Health X, leaving Health X focused solely on the healthcare business.

Segments

  • Healthcare Services
  • Financial Services
Technology-enabled fulfillment/warehousing space
over 2 lakh sq ft, expanding to over 8 lakh sq ft by FY27
Group subsidiaries
8 (incl. Sastasundar Healthbuddy, Microsec Resources (NBFC), Innogrow Technologies, Genu Path Labs, Bhartiya Sanskriti Village, Myjoy Technologies, Microsec Wealth Management)
Business segments
Healthcare Services, Financial Services

How the price took the results

close before → close after

Q1 FY27
−0.7%
11 Aug
Q4 FY26
−0.5%
19 Jun
Q3 FY26
+0.6%
16 Feb
Q2 FY26
+5.1%
17 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Health X Platform Limited

Free account: one company. Everything above stays public.

Write why you follow Health X Platform Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Health X Platform Limited

Guides on how to read this kind of business and the numbers that matter.